Detalhe da pesquisa
1.
The new direction of drug development: Degradation of undruggable targets through targeting chimera technology.
Med Res Rev
; 44(2): 632-685, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-37983964
2.
Development of Potent MALT1 Inhibitors Featuring a Novel "2-Thioxo-2,3-dihydrothiazolo[4,5-d]pyrimidin-7(6H)-one" Scaffold for the Treatment of B Cell Lymphoma.
J Med Chem
; 67(4): 2884-2906, 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38349664
3.
Differences in in vivo absorption of flavone glycosides, flavone aglycones and terpene lactones under different dosage forms and physiological conditions.
J Ethnopharmacol
; 306: 116159, 2023 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36649852
4.
Rh(III)-Catalyzed Synthesis of Substituted Isoindoles through a Direct C-H Activation/[4 + 1] Annulation and Acyl Migration Cascade of Oxadiazolones with Diazo Compounds.
Org Lett
; 25(18): 3195-3199, 2023 May 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37126790
5.
Discovery of Novel Imidazo[4,5-c]quinoline Derivatives to Treat Inflammatory Bowel Disease (IBD) by Inhibiting Multiple Proinflammatory Signaling Pathways and Restoring Intestinal Homeostasis.
J Med Chem
; 65(18): 11949-11969, 2022 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36053746